Optical Genome Mapping in Hematological Malignancies

NCT05009537 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-08-17

No results posted yet for this study

Summary

Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

Conditions

  • MDS
  • ALL
  • Other Hematologic Malignant Neoplasms

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2022-09-30
Completion
2026-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05009537 on ClinicalTrials.gov